The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients

Institutional Affiliations 

Chair

Costanzo MR: Midwest Heart Foundation, Lombard Illinois, USA

Task Force 1

Dipchand A: Hospital for Sick Children, Toronto Ontario, Canada; Starling R: Cleveland Clinic Foundation, Cleveland, Ohio, USA; Anderson A: University of Chicago, Chicago, Illinois, USA; Chan M: University of Alberta, Edmonton, Alberta, Canada; Desai S: Inova Fairfax Hospital, Fairfax, Virginia, USA; Fedson S: University of Chicago, Chicago, Illinois, USA; Fisher P: Ochsner Clinic, New Orleans, Louisiana, USA; Gonzales-Stawinski G: Cleveland Clinic Foundation, Cleveland, Ohio, USA; Martinelli L: Ospedale Niguarda, Milano, Italy; McGiffin D: University of Alabama, Birmingham, Alabama, USA; Parisi F: Ospedale Pediatrico Bambino Gesù, Rome, Italy; Smith J: Freeman Hospital, Newcastle upon Tyne, UK

Task Force 2

Taylor D: Cleveland Clinic Foundation, Cleveland, Ohio, USA; Meiser B: University of Munich/Grosshaden, Munich, Germany; Baran D: Newark Beth Israel Medical Center, Newark, New Jersey, USA; Carboni M: Duke University Medical Center, Durham, North Carolina, USA; Dengler T: University of Hidelberg, Heidelberg, Germany; Feldman D: Minneapolis Heart Institute, Minneapolis, Minnesota, USA; Frigerio M: Ospedale Niguarda, Milano, Italy; Kfoury A: Intermountain Medical Center, Murray, Utah, USA; Kim D: University of Alberta, Edmonton, Alberta, Canada; Kobashigawa J: Cedar-Sinai Heart Institute, Los Angeles, California, USA; Shullo M: University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Stehlik J: University of Utah, Salt Lake City, Utah, USA; Teuteberg J: University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Uber P: University of Maryland, Baltimore, Maryland, USA; Zuckermann A: University of Vienna, Vienna, Austria.

Task Force 3

Hunt S: Stanford University, Palo Alto, California, USA; Burch M: Great Ormond Street Hospital, London, UK; Bhat G: Advocate Christ Medical Center, Oak Lawn, Illinois, USA; Canter C: St. Louis Children Hospital, St. Louis, Missouri, USA; Chinnock R: Loma Linda University Children's Hospital, Loma Linda, California, USA; Crespo-Leiro M: Hospital Universitario A Coruña, La Coruña, Spain; Delgado R: Texas Heart Institute, Houston, Texas, USA; Dobbels F: Katholieke Universiteit Leuven, Leuven, Belgium; Grady K: Northwestern University, Chicago, Illlinois, USA; Kao W: University of Wisconsin, Madison Wisconsin, USA; Lamour J: Montefiore Medical Center, New York, New York, USA; Parry G: Freeman Hospital, Newcastle upon Tyne, UK; Patel J: Cedar-Sinai Heart Institute, Los Angeles, California, USA; Pini D: Istituto Clinico Humanitas, Rozzano, Italy; Pinney S: Mount Sinai Medical Center, New York, New York, USA; Towbin J: Cincinnati Children's Hospital, Cincinnati, Ohio, USA; Wolfel G: University of Colorado, Denver, Colorado, USA

Independent Reviewers

Delgado D: University of Toronto, Toronto, Ontario, Canada; Eisen H: Drexler University College of Medicine, Philadelphia, Pennsylvania, USA; Goldberg L: University of Pennsylvania, Philadelphia, Pennsylvania, USA; Hosenpud J: Mayo Clinic, Jacksonville, Florida, USA; Johnson M: University of Wisconsin, Madison, Wisconsin, USA; Keogh A: St Vincent Hospital, Sidney, New South Wales, Australia; Lewis C: Papworth Hospital Cambridge, UK; O'Connell J: St. Joseph Hospital, Atlanta, Georgia, USA; Rogers J: Duke University Medical Center, Durham, North Carolina, USA; Ross H: University of Toronto, Toronto, Ontario, Canada; Russell S: Johns Hopkins Hospital, Baltimore, Maryland, USA; Vanhaecke J: University Hospital Gasthuisberg, Leuven, Belgium.

Abbreviations: AAIR, atrium paced, atrium sensed inhibited rate modulation, ACC, American College of Cardiology, ACEI, angiotensin converting enzyme inhibitor, ACT, activated clotting time, ADA, American Diabetes Association, AHA, American Heart Association, AMR, antibody-mediated rejection, AP, aerosolized pentamidine, aPTT, activated partial thromboplastin time, ARB, angiotensin receptor blocker, ATG, anti-thymocyte globulin, AZA, azathioprine, BiV, biventricular, BMD, bone mass density, BNP, brain natriuretic peptide, CAV, cardiac allograft vasculopathy, CCB, calcium channel blocker, CEDIA, cloned enzyme donor immunoassay method, CI, cardiac index, CKD, chronic kidney disease, CO, cardiac output, CPB, cardiopulmonary bypass, CMV, cytomegalovirus, CNI, calcineurin inhibitor, CRP, C-reactive protein, CS, corticosteroid, CT, computed tomography, CVP, central venous pressure, CYA, cyclosporine, CYP3A, cytochrome P-450 3A4, DDDR, dual-paced, dual-sensed, dual-response to sensing, rate modulation, DEXA, dual energy x-ray absorptiometry, DSA, donor specific antibody, ECG, electrocardiogram, ED, erectile dysfunction, ECMO, extracorporeal membrane oxygenation, EMB, endomyocardial biopsy, EMIT, enzyme multiplied immunoassay technique, ESC, European Society of Cardiology, EVL, everolimus, FFP, fresh frozen plasma, GFR, glomerular filtration rate, Hgb, hemoglobin, HIT, heparin-induced thrombocytopenia, HLA, human leukocyte antigen, HPLC, high-performance liquid chromatography, HPV, human papillomavirus, HRS, Heart Rhythm Society, HSV, herpes simplex virus, HT, heart transplant, ICU, intensive care unit, Ig, immunoglobulin, IgG, immunoglobulin G, INR, international normalized unit, ISHLT, International Society for Heart and Lung Transplantation, IUD, intrauterine device, IV, intravenous, IVUS, intravascular ultrasound, LV, left ventricle, LVEF, left ventricular ejection fraction, LVH, left ventricular hypertrophy, MAOI, monoamine oxidase inhibitors, MCS, mechanical circulatory support, MDRD equation, modified diet in renal disease equation, MMF, mycophenolate mofetil, MPA, mycophenolic acid, mTOR, mammalian target of rapamycin, MVO₂, mixed venous oxygen, PAWP, pulmonary artery wedge pressure, PCC, prothrombin plasma concentrates, PFA-100, platelets function assay 100, PGF, primary graft failure, PRA, panel reactive antibodies, PRES, posterior reversible leukoencephalopathy, PSI, proliferation signal inhibitor, PTLD, posttransplant lymphoproliferative disorder, PT, prothrombin time, PTT, partial thromboplastin time, PVR, pulmonary vascular resistance, RAP, right atrial pressure, rFVII, recombinant factor 7, RV, right ventricle, sCr, serum creatinine, SRL, sirolimus, STI, sexually transmitted infection, SVT, sustained ventricular tachycardia, TAC, tacrolimus, TEE, transesophageal echocardiogram, TMP/SMZ, trimethoprim/sulfamethoxazole, TTE, transthoracic echocardiogram, TV, tricuspid valve, VAD, ventricular assist device, VER, ventricular evoked responses, VT, ventricular tachycardia